Meet the guy biohacking puppies to make them glow in the dark
By Kristen V. Brown,
Fusion
| 09. 28. 2016
It was after a home invasion almost a decade ago that David Ishee first got interested in breeding dogs. A burglar with a gun had broken into his home in Jackson, Mississippi, where Ishee was asleep along with his wife, 3-year-old-daughter and newborn son. Ishee pulled out his own shotgun and scared the would-be thief off. But he was unsettled wondering what might have happened had he not been around.
Ishee wanted a guard dog, and giant, docile mastiffs are good ones to have around little kids. Like so many carefully bred dogs, though, mastiffs are riddled with genetic disorders. So Ishee decided to start breeding them himself, with plans to increase their genetic diversity and hopefully make them healthier, happier and more fit. Over just a few generations, he saw results. Gone was the sagging skin and oversized head that makes so many mastiffs look goofy. He told me his dogs could jump higher and run faster than most other Mastiffs can.
But because the majority of the genetic disorders dogs suffer from are recessive, Ishee...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...